Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000922 | spindle pole | 2 | 2 |
GO:0005737 | cytoplasm | 2 | 12 |
GO:0005813 | centrosome | 3 | 2 |
GO:0005814 | centriole | 5 | 12 |
GO:0005815 | microtubule organizing center | 2 | 2 |
GO:0036064 | ciliary basal body | 3 | 2 |
GO:0043226 | organelle | 2 | 12 |
GO:0043228 | non-membrane-bounded organelle | 3 | 12 |
GO:0043229 | intracellular organelle | 3 | 12 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005929 | cilium | 4 | 10 |
GO:0042995 | cell projection | 2 | 10 |
GO:0043227 | membrane-bounded organelle | 3 | 10 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 10 |
Related structures:
AlphaFold database: Q4Q4L1
Term | Name | Level | Count |
---|---|---|---|
GO:0000226 | microtubule cytoskeleton organization | 3 | 2 |
GO:0006903 | vesicle targeting | 2 | 2 |
GO:0006996 | organelle organization | 4 | 2 |
GO:0007010 | cytoskeleton organization | 5 | 2 |
GO:0007017 | microtubule-based process | 2 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0034453 | microtubule anchoring | 4 | 2 |
GO:0034454 | microtubule anchoring at centrosome | 6 | 2 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 3 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
GO:0072393 | microtubule anchoring at microtubule organizing center | 5 | 2 |
GO:0097712 | vesicle targeting, trans-Golgi to periciliary membrane compartment | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 280 | 284 | PF00656 | 0.447 |
CLV_C14_Caspase3-7 | 312 | 316 | PF00656 | 0.458 |
CLV_C14_Caspase3-7 | 82 | 86 | PF00656 | 0.434 |
CLV_NRD_NRD_1 | 18 | 20 | PF00675 | 0.414 |
CLV_NRD_NRD_1 | 202 | 204 | PF00675 | 0.319 |
CLV_NRD_NRD_1 | 22 | 24 | PF00675 | 0.418 |
CLV_NRD_NRD_1 | 221 | 223 | PF00675 | 0.264 |
CLV_NRD_NRD_1 | 25 | 27 | PF00675 | 0.397 |
CLV_PCSK_KEX2_1 | 129 | 131 | PF00082 | 0.450 |
CLV_PCSK_KEX2_1 | 202 | 204 | PF00082 | 0.298 |
CLV_PCSK_KEX2_1 | 22 | 24 | PF00082 | 0.404 |
CLV_PCSK_KEX2_1 | 221 | 223 | PF00082 | 0.193 |
CLV_PCSK_KEX2_1 | 348 | 350 | PF00082 | 0.248 |
CLV_PCSK_KEX2_1 | 80 | 82 | PF00082 | 0.486 |
CLV_PCSK_PC1ET2_1 | 129 | 131 | PF00082 | 0.450 |
CLV_PCSK_PC1ET2_1 | 348 | 350 | PF00082 | 0.248 |
CLV_PCSK_PC1ET2_1 | 80 | 82 | PF00082 | 0.580 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.360 |
CLV_PCSK_SKI1_1 | 222 | 226 | PF00082 | 0.339 |
CLV_PCSK_SKI1_1 | 335 | 339 | PF00082 | 0.287 |
DEG_SPOP_SBC_1 | 277 | 281 | PF00917 | 0.388 |
DOC_CKS1_1 | 159 | 164 | PF01111 | 0.307 |
DOC_MAPK_gen_1 | 26 | 34 | PF00069 | 0.481 |
DOC_MAPK_gen_1 | 291 | 299 | PF00069 | 0.539 |
DOC_MAPK_RevD_3 | 115 | 130 | PF00069 | 0.441 |
DOC_MAPK_RevD_3 | 334 | 349 | PF00069 | 0.491 |
DOC_USP7_MATH_1 | 251 | 255 | PF00917 | 0.521 |
DOC_USP7_MATH_1 | 277 | 281 | PF00917 | 0.499 |
DOC_USP7_MATH_1 | 355 | 359 | PF00917 | 0.541 |
DOC_WW_Pin1_4 | 158 | 163 | PF00397 | 0.330 |
DOC_WW_Pin1_4 | 247 | 252 | PF00397 | 0.557 |
DOC_WW_Pin1_4 | 278 | 283 | PF00397 | 0.552 |
DOC_WW_Pin1_4 | 55 | 60 | PF00397 | 0.528 |
LIG_14-3-3_CanoR_1 | 108 | 115 | PF00244 | 0.400 |
LIG_14-3-3_CanoR_1 | 168 | 174 | PF00244 | 0.584 |
LIG_14-3-3_CanoR_1 | 222 | 231 | PF00244 | 0.448 |
LIG_14-3-3_CanoR_1 | 67 | 72 | PF00244 | 0.496 |
LIG_deltaCOP1_diTrp_1 | 9 | 18 | PF00928 | 0.469 |
LIG_FHA_1 | 185 | 191 | PF00498 | 0.548 |
LIG_FHA_1 | 214 | 220 | PF00498 | 0.449 |
LIG_FHA_1 | 259 | 265 | PF00498 | 0.535 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.464 |
LIG_FHA_2 | 318 | 324 | PF00498 | 0.465 |
LIG_FHA_2 | 34 | 40 | PF00498 | 0.507 |
LIG_LIR_Apic_2 | 191 | 195 | PF02991 | 0.539 |
LIG_LIR_Gen_1 | 233 | 241 | PF02991 | 0.557 |
LIG_LIR_Gen_1 | 58 | 69 | PF02991 | 0.462 |
LIG_LIR_Gen_1 | 9 | 18 | PF02991 | 0.360 |
LIG_LIR_Nem_3 | 187 | 192 | PF02991 | 0.539 |
LIG_LIR_Nem_3 | 233 | 239 | PF02991 | 0.490 |
LIG_LIR_Nem_3 | 323 | 327 | PF02991 | 0.539 |
LIG_LIR_Nem_3 | 9 | 14 | PF02991 | 0.357 |
LIG_MYND_1 | 115 | 119 | PF01753 | 0.438 |
LIG_PCNA_PIPBox_1 | 87 | 96 | PF02747 | 0.396 |
LIG_PCNA_yPIPBox_3 | 80 | 94 | PF02747 | 0.395 |
LIG_PTB_Apo_2 | 326 | 333 | PF02174 | 0.539 |
LIG_SH2_NCK_1 | 192 | 196 | PF00017 | 0.539 |
LIG_SH2_SRC | 103 | 106 | PF00017 | 0.344 |
LIG_SH2_STAP1 | 103 | 107 | PF00017 | 0.341 |
LIG_SH2_STAP1 | 346 | 350 | PF00017 | 0.448 |
LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.497 |
LIG_SH2_STAT5 | 344 | 347 | PF00017 | 0.480 |
LIG_SH3_3 | 156 | 162 | PF00018 | 0.408 |
LIG_SH3_3 | 209 | 215 | PF00018 | 0.469 |
LIG_SH3_3 | 279 | 285 | PF00018 | 0.457 |
LIG_SH3_3 | 333 | 339 | PF00018 | 0.456 |
LIG_SH3_3 | 349 | 355 | PF00018 | 0.476 |
LIG_SH3_3 | 41 | 47 | PF00018 | 0.582 |
LIG_SUMO_SIM_par_1 | 49 | 54 | PF11976 | 0.327 |
LIG_TRAF2_1 | 28 | 31 | PF00917 | 0.381 |
LIG_TRAF2_1 | 320 | 323 | PF00917 | 0.462 |
LIG_UBA3_1 | 71 | 80 | PF00899 | 0.398 |
MOD_CDK_SPK_2 | 158 | 163 | PF00069 | 0.354 |
MOD_CK1_1 | 254 | 260 | PF00069 | 0.463 |
MOD_CK1_1 | 353 | 359 | PF00069 | 0.582 |
MOD_CK2_1 | 140 | 146 | PF00069 | 0.408 |
MOD_CK2_1 | 317 | 323 | PF00069 | 0.447 |
MOD_CK2_1 | 33 | 39 | PF00069 | 0.504 |
MOD_CK2_1 | 67 | 73 | PF00069 | 0.521 |
MOD_DYRK1A_RPxSP_1 | 158 | 162 | PF00069 | 0.271 |
MOD_GlcNHglycan | 109 | 112 | PF01048 | 0.398 |
MOD_GlcNHglycan | 288 | 291 | PF01048 | 0.301 |
MOD_GlcNHglycan | 358 | 361 | PF01048 | 0.304 |
MOD_GSK3_1 | 176 | 183 | PF00069 | 0.473 |
MOD_GSK3_1 | 247 | 254 | PF00069 | 0.501 |
MOD_GSK3_1 | 260 | 267 | PF00069 | 0.430 |
MOD_GSK3_1 | 272 | 279 | PF00069 | 0.473 |
MOD_GSK3_1 | 63 | 70 | PF00069 | 0.461 |
MOD_N-GLC_1 | 277 | 282 | PF02516 | 0.275 |
MOD_N-GLC_1 | 98 | 103 | PF02516 | 0.463 |
MOD_NEK2_1 | 107 | 112 | PF00069 | 0.348 |
MOD_NEK2_1 | 89 | 94 | PF00069 | 0.436 |
MOD_PIKK_1 | 353 | 359 | PF00454 | 0.457 |
MOD_PKA_2 | 107 | 113 | PF00069 | 0.414 |
MOD_PKA_2 | 174 | 180 | PF00069 | 0.490 |
MOD_Plk_1 | 317 | 323 | PF00069 | 0.437 |
MOD_Plk_2-3 | 317 | 323 | PF00069 | 0.447 |
MOD_Plk_4 | 184 | 190 | PF00069 | 0.539 |
MOD_Plk_4 | 235 | 241 | PF00069 | 0.490 |
MOD_Plk_4 | 67 | 73 | PF00069 | 0.552 |
MOD_Plk_4 | 89 | 95 | PF00069 | 0.434 |
MOD_ProDKin_1 | 158 | 164 | PF00069 | 0.333 |
MOD_ProDKin_1 | 247 | 253 | PF00069 | 0.557 |
MOD_ProDKin_1 | 278 | 284 | PF00069 | 0.552 |
MOD_ProDKin_1 | 55 | 61 | PF00069 | 0.525 |
MOD_SUMO_rev_2 | 317 | 327 | PF00179 | 0.448 |
TRG_DiLeu_BaEn_1 | 9 | 14 | PF01217 | 0.370 |
TRG_ENDOCYTIC_2 | 61 | 64 | PF00928 | 0.372 |
TRG_ER_diArg_1 | 201 | 203 | PF00400 | 0.482 |
TRG_ER_diArg_1 | 21 | 23 | PF00400 | 0.396 |
TRG_ER_diArg_1 | 221 | 223 | PF00400 | 0.419 |
TRG_NLS_MonoExtC_3 | 18 | 23 | PF00514 | 0.392 |
TRG_Pf-PMV_PEXEL_1 | 81 | 85 | PF00026 | 0.475 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I6Z2 | Leptomonas seymouri | 57% | 95% |
A0A0S4JKX9 | Bodo saltans | 35% | 100% |
A0A1X0P0L9 | Trypanosomatidae | 39% | 94% |
A0A3R7KC81 | Trypanosoma rangeli | 40% | 96% |
A0A3S7X6D1 | Leishmania donovani | 94% | 100% |
A4HL49 | Leishmania braziliensis | 79% | 100% |
A4I8M8 | Leishmania infantum | 94% | 100% |
D0A4K6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 96% |
E9B3J0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
V5BKD3 | Trypanosoma cruzi | 41% | 96% |